Dr. Robert Kaufman and the new ValidCare Safety Study on CBD

Hemp Industry Episode Resources:

Host: Jonathan Miller
Guest: Dr. Robert Kaufman
Blog: Hemp Legally Speaking

Hemp Industry questions covered in the episode:

1. What does the ValidCare study demonstrate about the safety of ingestible CBD?
2. What did the study conclude about CBD’s liver toxicity and how does this contrast with studies done on Epidiolex, the CBD drug used by children with rare forms of epilepsy?
3. How does the study address concerns about drowsiness and low testosterone?
4. Statistically speaking, how strong are the study’s conclusions
5. What’s the message that Dr. Kaufman will be sharing with FDA in its upcoming meeting?